Dosage prescribed is determined by the licensed provider based on medical judgment.
GLP-1 (glucagon-like peptide-1) is a hormone-based medication originally developed to improve blood sugar control in people with type 2 diabetes by enhancing insulin release, slowing gastric emptying, and reducing glucagon secretion. Clinical research has since shown that it also acts on appetite centers in the brain to increase satiety, lower food intake, and support weight reduction. Because of its dual effects on glucose regulation and appetite control, GLP-1 therapy is now recognized as both an effective diabetes treatment and a scientifically validated option for long-term weight management and metabolic health.
GLP-1 is a prescription medication that is prescribed for weight loss and Type 2 Diabetes. It belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists. It mimics the action of GLP-1, a hormone that stimulates the release of insulin and reduces the amount of glucose produced by the liver. This helps lower blood sugar levels in people with diabetes.
GLP-1 also reduces the speed at which food passes through the digestive system. It prolongs digestion, helping to maintain your feeling of fullness for a longer period. Therefore, when you take GLP-1 injections, you feel fuller faster and are less likely to overeat.
One of the key benefits of GLP-1 is its ability to suppress appetite, helping you feel fuller for longer and reducing cravings for unhealthy foods. By curbing your appetite, GLP-1 makes it easier to stick to your dietary goals and maintain a healthy lifestyle.
GLP-1 also plays a crucial role in regulating blood sugar levels. By enhancing insulin sensitivity and reducing glucose production in the liver, GLP-1 helps keep blood sugar levels stable, which is essential for overall health and well-being.
WHY IT MATTERS
Improves blood sugar and reduces insulin by increasing glucose uptake
Its ability to reduce insulin, a fat storage hormone, can also support weight loss
Associated with reduced risk of cancer, cardiovascular disease, and neurodegenerative disease
By reducing chronic disease risk, metformin has been linked to increased longevity
